122 related articles for article (PubMed ID: 7516564)
21. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
[TBL] [Abstract][Full Text] [Related]
22. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
24. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
[TBL] [Abstract][Full Text] [Related]
25. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
26. The same few V genes account for a majority of oxazolone antibodies in most mouse strains.
Solin ML; Kaartinen M; Mäkelä O
Mol Immunol; 1992 Nov; 29(11):1357-62. PubMed ID: 1406722
[TBL] [Abstract][Full Text] [Related]
27. Lipid-tagged antibodies: bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein.
Laukkanen ML; Teeri TT; Keinänen K
Protein Eng; 1993 Jun; 6(4):449-54. PubMed ID: 8332603
[TBL] [Abstract][Full Text] [Related]
28. The repertoire of antibodies to a single antigenic determinant.
Wang D; Liao J; Mitra D; Akolkar PN; Gruezo F; Kabat EA
Mol Immunol; 1991 Dec; 28(12):1387-97. PubMed ID: 1721104
[No Abstract] [Full Text] [Related]
29. Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding.
Stanfield RL; Dooley H; Verdino P; Flajnik MF; Wilson IA
J Mol Biol; 2007 Mar; 367(2):358-72. PubMed ID: 17258766
[TBL] [Abstract][Full Text] [Related]
30. High-level production of an active single-chain Fv fragment in the culture supernatant of Escherichia coli.
Sizmann D; Takkinen K; Laukkanen ML; Saloheimo M; Candussio A; Veijola-Bailey P; Teeri TT
Year Immunol; 1993; 7():119-30. PubMed ID: 8372501
[No Abstract] [Full Text] [Related]
31. Somatic mutation of immunoglobulin V genes in vitro.
Källberg E; Jainandunsing S; Gray D; Leanderson T
Science; 1996 Mar; 271(5253):1285-9. PubMed ID: 8638111
[TBL] [Abstract][Full Text] [Related]
32. Analysis of somatic mutation activity in multiple V kappa genes involved in the response to 2-phenyl-5-oxazolone.
Källberg E; Gray D; Leanderson T
Int Immunol; 1993 Jun; 5(6):573-81. PubMed ID: 8347553
[TBL] [Abstract][Full Text] [Related]
33. Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms.
Mylvaganam SE; Paterson Y; Kaiser K; Bowdish K; Getzoff ED
J Mol Biol; 1991 Sep; 221(2):455-62. PubMed ID: 1656053
[TBL] [Abstract][Full Text] [Related]
34. A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding.
Kobrin BJ; Buhl S; Shulman MJ; Scharff MD
J Immunol; 1991 Mar; 146(6):2017-20. PubMed ID: 2005389
[TBL] [Abstract][Full Text] [Related]
35. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
36. Anti-oxazolone hybridomas and the structure of the oxazolone idiotype.
Kaartinen M; Griffiths GM; Hamlyn PH; Markham AF; Karjalainen K; Pelkonen JL; Mäkelä O; Milstein C
J Immunol; 1983 Feb; 130(2):937-45. PubMed ID: 6401310
[TBL] [Abstract][Full Text] [Related]
37. Somatic origin of T-cell epitopes within antibody variable regions: significance to monoclonal therapy and genesis of systemic autoimmune disease.
Wysocki LJ; Zhang X; Smith DS; Snyder CM; Bonorino C
Immunol Rev; 1998 Apr; 162():233-46. PubMed ID: 9602368
[TBL] [Abstract][Full Text] [Related]
38. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
[TBL] [Abstract][Full Text] [Related]
39. Engineering scFvs for improved stability.
Chowdhury PS; Vasmatzis G
Methods Mol Biol; 2003; 207():237-54. PubMed ID: 12412478
[No Abstract] [Full Text] [Related]
40. Primary sequence and molecular model of the variable region of a mouse monoclonal anti-Der p 1 antibody showing a similar epitope specificity as human IgE.
McElveen JE; Clark MR; Smith SJ; Sewell HF; Shakib F
Clin Exp Allergy; 1998 Nov; 28(11):1427-34. PubMed ID: 9824417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
